Astrana Health Inc [ASTH] stock is trading at $28.69, up 2.17%. An important factor to consider is whether the stock is rising or falling in short-term value. The ASTH shares have gain 31.12% over the last week, with a monthly amount glided 15.22%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Astrana Health Inc [NASDAQ: ASTH] stock has seen the most recent analyst activity on April 01, 2025, when Barclays initiated its Equal Weight rating and assigned the stock a price target of $36. Previously, TD Cowen started tracking the stock with Buy rating on October 14, 2024, and set its price target to $66. On October 11, 2024, KeyBanc Capital Markets initiated with a Sector Weight rating. Truist upgraded its rating to a Buy and increased its price target to $50 on July 11, 2024. Robert W. Baird initiated its recommendation with a Outperform and recommended $54 as its price target on May 30, 2024. Jefferies started tracking with a Buy rating for this stock on February 26, 2024, and assigned it a price target of $50. In a note dated February 22, 2024, BofA Securities upgraded an Buy rating on this stock and boosted its target price from $44 to $55.
Astrana Health Inc [ASTH] stock has fluctuated between $21.20 and $63.20 over the past year. Currently, Wall Street analysts expect the stock to reach $43 within the next 12 months. Astrana Health Inc [NASDAQ: ASTH] shares were valued at $28.69 at the most recent close of the market. An investor can expect a potential return of 49.88% based on the average ASTH price forecast.
Analyzing the ASTH fundamentals
Astrana Health Inc [NASDAQ:ASTH] reported sales of 2.42B for the trailing twelve months, which represents a growth of 34.66%. Gross Profit Margin for this corporation currently stands at 0.12% with Operating Profit Margin at 0.03%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.04 and Total Capital is 0.1. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 27.41 points at the first support level, and at 26.14 for the second support level. However, for the 1st resistance point, the stock is sitting at 30.11, and for the 2nd resistance point, it is at 31.54.
Ratios To Look Out For
For context, Astrana Health Inc’s Current Ratio is 1.59. On the other hand, the Quick Ratio is 1.59, and the Cash Ratio is 1.77. Considering the valuation of this stock, the price to sales ratio is 0.59, the price to book ratio is 1.84 and price to earnings (TTM) ratio is 55.58.
